Nicotine Science and Policy
By Harry Shapiro Aug. 13, 2026
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
October 27, 2026 by clearingtheair.eu
Ireland vape flavour restrictions clear final Seanad stage
Ireland's proposed vape flavour restrictions have cleared their final Seanad stages, despite warnings from retailers and former smokers about their potential consequences.
The legislation would restrict permitted flavour names to tobacco and unflavoured, with an amendment to retain menthol defeated. Combined with a planned 40% increase in e-liquid duty from January 2027, the measures could make vaping less affordable and appealing to adults who have already quit smoking.
While preventing youth uptake remains essential, policymakers must also consider the risk of smoking relapse and the potential impact on independent vape retailers. Effective tobacco control should protect young people without undermining progress towards a smoke-free society.
October 27, 2026 by consideratepouchers.org
Four times Sweden's tax: inside the EU's new plan for nicotine pouches
The EU's latest tobacco tax proposal could introduce a minimum excise duty on nicotine pouches more than four times Sweden's current rate by 2032.
Under the draft agreement, taxation would increase progressively from 2028, potentially affecting the affordability of smoke-free nicotine alternatives across Europe. Sweden has raised objections, arguing that taxation should reflect differences in product risk.
The proposal raises important questions for tobacco harm reduction. Higher taxes on lower-risk products could weaken financial incentives for smokers to switch, highlighting the need for a risk-proportionate approach to nicotine taxation.
October 27, 2026 by politico.eu
Belgium postpones terrace smoking ban
Belgium has postponed its planned ban on smoking and vaping on café and restaurant terraces, originally scheduled for January 2027, following objections from the Council of State and concerns raised by the hospitality sector.
The delay gives policymakers an opportunity to reconsider how restrictions on smoking and vaping are applied. Protecting people from second-hand smoke remains an important public health objective, but regulation should also recognise differences in exposure and risk between combustible cigarettes and smoke-free alternatives. A proportionate approach can support smoke-free environments without overlooking tobacco harm reduction.
21.70% of the adult population are current smokers. There are approximately 2.1 million current smokers in Belgium 24.70% of men are current smokers but only 18.90% of women.
SOURCE: GSTHR
October 26, 2026 by thr101.org
Hawaii Youth Vaping Plunges as More Adults Vape Than Smoke
Youth vaping in Hawaii declined by 66% between 2019 and 2025, while cigarette smoking among high school students reached its lowest recorded level. Meanwhile, more adults now report vaping than smoking, according to newly released survey data.
Despite these trends, Hawaii is introducing further restrictions on vaping products, including tighter authorisation requirements and limits on disposable devices.
The findings highlight the importance of balancing youth protection with adult access to lower-risk alternatives, particularly as policymakers consider the potential effects of additional restrictions on smoking cessation and tobacco harm reduction.
14.10% of the adult population are current smokers. There are approximately 39.8 million current smokers in United States 17.10% of men are current smokers but only 11.10% of women.
SOURCE: GSTHR
October 26, 2026 by substack.com
Mice studies to simulate children exposure to “third hand” vaping are toxicological fiction
Animal studies investigating children's exposure to residual vaping aerosol have come under scrutiny for using experimental conditions that may not reflect real-world exposure.
Researcher Roberto Sussman questions the relevance of mouse studies that expose animals to heavily contaminated materials, highlighting the lack of evidence for comparable exposure levels in everyday environments where children live.
The analysis reinforces the importance of realistic exposure assessment and scientifically valid comparisons between vaping and smoking. Reliable tobacco harm reduction research must distinguish laboratory findings from risks demonstrated under real-world conditions.
- Page 1 of 46
Blogs
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
Harry’s blog 133: Silence is consent
Two tobacco control consultations that demand your attention
I’m sure there are many of you like me who are deeply cynical about public consultations. They often feel like political tick box exercises allowing the issuing authority from local councils to international organisations to say they have ‘consulted with the people’, when in truth they knew exactly what they were going to do from the get-go.
Harry’s Blog 132: “Zyn! Went The Strings Of My Heart” (with apologies to Judy Garland)
FDA approval of 20 nicotine pouch products is another step forward for tobacco harm reduction
The FDA in the U.S. has granted marketing authorisation for Zyn nicotine pouch products (five variations on mint plus five other flavours in two different strengths).
In its letter to PMI (who own Zyn manufacturers Swedish Match), the FDA wrote:
Based on our review of your MRTPAs [Modified Risk Tobacco Applications] we determined that the proposed modified risk tobacco products, …as actually used by consumers would significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products. Therefore, we authorize marketing of the tobacco products as modified risk tobacco products with the following modified risk information – “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis”.